Transcend Capital Advisors LLC lowered its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 43.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,572 shares of the semiconductor company’s stock after selling 1,213 shares during the period. Transcend Capital Advisors LLC’s holdings in Synopsys were worth $738,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Alpine Bank Wealth Management increased its position in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares during the last quarter. TFC Financial Management Inc. increased its position in shares of Synopsys by 1,250.0% in the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 50 shares during the last quarter. Millstone Evans Group LLC bought a new stake in shares of Synopsys in the 3rd quarter worth about $27,000. SOA Wealth Advisors LLC. bought a new stake in shares of Synopsys in the 3rd quarter worth about $28,000. Finally, Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys in the 4th quarter worth about $28,000. Institutional investors own 85.47% of the company’s stock.
Synopsys Stock Performance
Shares of NASDAQ SNPS opened at $438.45 on Thursday. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. The firm’s 50-day moving average price is $421.19 and its two-hundred day moving average price is $445.84. Synopsys, Inc. has a 52-week low of $376.18 and a 52-week high of $651.73. The stock has a market capitalization of $83.99 billion, a P/E ratio of 68.08, a P/E/G ratio of 3.42 and a beta of 1.15.
Analyst Ratings Changes
Several equities research analysts have recently weighed in on SNPS shares. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a research report on Thursday, January 22nd. Wells Fargo & Company dropped their target price on shares of Synopsys from $500.00 to $450.00 and set an “equal weight” rating for the company in a research report on Thursday, February 26th. Morgan Stanley reissued an “equal weight” rating and issued a $480.00 target price (down from $550.00) on shares of Synopsys in a research report on Wednesday, February 25th. HSBC downgraded shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a research report on Friday, February 20th. Finally, Needham & Company LLC reissued a “buy” rating on shares of Synopsys in a research report on Thursday, February 26th. Eight research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $531.00.
Check Out Our Latest Analysis on Synopsys
Synopsys Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
